Spero Therapeutics, Inc.
SPRO • NASDAQ • Stock Fundamentals
Spero Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Esther Rajavelu, with a market cap of $159.8M.
Market Cap$159.8M
Employees46.0
CEOEsther Rajavelu
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Spero Therapeutics, Inc. FAQ
Common questions about Spero Therapeutics, Inc.
Spero Therapeutics, Inc. (SPRO) has a market capitalization of $159.8M and trades on NASDAQ.
Spero Therapeutics, Inc. has approximately 46 employees.